- Home
- PC vs BCLI Comparison
PC vs BCLI Comparison
Compare PC & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PC
- BCLI
- Stock Information
- Founded
- PC 2012
- BCLI 2000
- Country
- PC Singapore
- BCLI United States
- Employees
- PC N/A
- BCLI N/A
- Industry
- PC Restaurants
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PC Consumer Discretionary
- BCLI Health Care
- Exchange
- PC Nasdaq
- BCLI Nasdaq
- Market Cap
- PC 11.1M
- BCLI 9.1M
- IPO Year
- PC 2024
- BCLI N/A
- Fundamental
- Price
- PC $0.78
- BCLI $2.25
- Analyst Decision
- PC
- BCLI Strong Buy
- Analyst Count
- PC 0
- BCLI 1
- Target Price
- PC N/A
- BCLI $30.00
- AVG Volume (30 Days)
- PC 218.3K
- BCLI 112.8K
- Earning Date
- PC 12-24-2024
- BCLI 11-14-2024
- Dividend Yield
- PC N/A
- BCLI N/A
- EPS Growth
- PC N/A
- BCLI N/A
- EPS
- PC N/A
- BCLI N/A
- Revenue
- PC $3,809,288.00
- BCLI N/A
- Revenue This Year
- PC N/A
- BCLI N/A
- Revenue Next Year
- PC N/A
- BCLI N/A
- P/E Ratio
- PC N/A
- BCLI N/A
- Revenue Growth
- PC N/A
- BCLI N/A
- 52 Week Low
- PC $0.60
- BCLI $1.05
- 52 Week High
- PC $5.73
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- PC N/A
- BCLI 70.03
- Support Level
- PC N/A
- BCLI $1.45
- Resistance Level
- PC N/A
- BCLI $1.72
- Average True Range (ATR)
- PC 0.00
- BCLI 0.18
- MACD
- PC 0.00
- BCLI 0.08
- Stochastic Oscillator
- PC 0.00
- BCLI 84.69
About PC Premium Catering (Holdings) Limited Ordinary Shares
Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. They specialize in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.